SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoats Group Plc Regulatory News (COA)

Share Price Information for Coats Group Plc (COA)

Share Price is delayed by 15 minutes
Get Live Data
79.95    1.45 (1.85%)
Bid:
79.45
Ask:
79.60
Spread: 0.15 (0.189%)
Market Cap: £1.53b
COA Live PriceLast checked at - London Stock Exchange

Intraday Coats Group Plc Share Chart

Trading Statement

27 Mar 2020 07:00

RNS Number : 7885H
Coats Group PLC
27 March 2020
 

27 March 2020

Coats Group plc

Update on trading and impact of Covid-19

Coats Group plc ('Coats,' the 'Company' or the 'Group'), the world's leading industrial thread manufacturer, today provides an update on trading and the impact of Covid-19.

 

In the light of the recent escalation in the Covid-19 outbreak we are particularly focused on 3 priorities in the immediate future. These are 1) continuing to ensure the health and safety of our employees, 2) cash management, and 3) supporting our customers and maintaining the critical elements of our supply chain.

Current trading and outlook

Sales in the first two months of 2020, aside from the previously stated $8 million adverse impact on our China business as a result of Covid-19, were broadly in line with expectations. Since reporting our Full Year 2019 Results on 5 March we have seen the global situation escalate within and beyond the industries in which we operate. This has begun to impact our global demand in March, as brands and manufacturers started to cancel or defer orders, for example due to large scale store closures. In addition, as at 26 March, due to enforced government closures, 15 of our around 50 manufacturing sites are currently subject to temporary shutdown. Indications from those governments are that these sites will return to production in the coming weeks, however we cannot rule out further enforced government closures in these and other geographies.

As a result of this, our Q1 2020 organic revenues will be around 8% down on Q1 2019, with an accelerating organic decline in March, which is expected to be around 15% down year-on-year. Due to current uncertainty over the level of demand reduction across the Group, we are not able at this stage to make accurate forecasts over Full Year 2020 revenues.

Balance Sheet strength

We entered 2020 with a robust Balance Sheet and generating significant levels of cash, which place us in a strong position to manage through this period.

Our committed debt facilities total $575 million across our Banking and US Private Placement group, with a range of maturities from late 2022 through to 2027, and at the end of 2019 we had $290 million of headroom available.

At the end of February, this headroom was $230 million, which is reduced from December 2019 due to the payment of $37 million for the Pharr High Performance Yarns acquisition in February, and normal working capital outflows in Q1. Our debt covenants are two-fold: leverage of no more than 3x EBITDA (0.65x at December 2019) and interest cover of no less than 4x (12.9x at December 2019), which both exclude the impacts of IFRS 16.

Whilst the outlook remains uncertain, we have performed scenario testing, including a significant decline in sales in Q2 and Q3, with a gradual improvement in Q4, which equates to a 30% organic sales decline for the Full Year. In this scenario we still project to operate within our existing facility headroom and covenants.

Management actions

Despite the uncertain environment, we remain confident in our ability to navigate our way through these difficult times. We are taking all necessary actions internally to manage our cost base and cash resources prudently.

These extensive actions include, but are not limited to, significantly reducing our 2020 capital expenditure by c.$30 million from $45-55 million to $15-25 million, temporarily flexing our manufacturing footprint, and reviewing all non-essential discretionary spend. In addition, the Board and Group Executive Team will take a 20% reduction in their salary and fees in Q2. We are also exploring all available government support schemes being put in place around the world, in relation to Covid-19. On cash actions, we are focused on managing our working capital, including heightened credit risk.

Finally, the Board has decided to cancel the proposed 2019 final dividend which was due to be approved at our forthcoming AGM in May. The Board will keep the 2020 interim dividend under review.

Conclusion

Despite these uncertain times, the Board remains confident in the Group's ability to successfully manage through this difficult period and our actions are the prudent ones to take at this time. We enter this phase of our 250+ year history in robust shape and as a market leader with an unrivalled global footprint. Alongside our enhanced operational agility this leaves us well placed to benefit from an acceleration in demand when the virus situation is resolved.

 

Our next scheduled update to the market will be our January-April 2020 trading update on 20 May 2020, prior to our 2020 Annual General Meeting. We will update the market sooner, if required, as events evolve.

 

 

 

 

Enquiry details

Investors

Rob Mann

Coats Group plc

+44 (0)20 8210 5175

Media

Richard Mountain / Nick Hasell

FTI Consulting

+44 (0)20 3727 1374

_________________________________________________________________________________________

 

 

This announcement contains inside information for the purposes of the Market Abuse Regulation.

 

 

About Coats Group plc

Coats is the world's leading industrial thread company. At home in some 50 countries, Coats has a workforce of 17,000 people across six continents. Revenues in 2019 were US$1.4bn. Coats' pioneering history and innovative culture ensure the company continues leading the way around the world. It provides complementary and value added products, services and software solutions to the apparel and footwear industries. It applies innovative techniques to develop high technology Performance Materials threads, yarns and fabrics in areas such as Transportation, Telecommunications and Energy, and Personal Protection. Headquartered in the UK, Coats is a FTSE 250 company, a constituent of the FTSE4Good Index Series and a participant in the UN Global Compact. To find out more about Coats visit www.coats.com.

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKABNFBKDDNB
Date   Source Headline
8th Jun 20269:23 amRNSHolding(s) in Company
20th May 20264:16 pmRNSResult of AGM
20th May 20267:00 amRNSTrading Statement
14th May 202611:00 amRNSAppointment of Chair
6th May 202611:00 amRNSDirectorate change
24th Apr 20261:15 pmRNSHolding(s) in Company
8th Apr 202611:00 amRNSDirector Declaration
30th Mar 202611:15 amRNSDirector/PDMR Shareholding
24th Mar 202611:08 amRNSHolding(s) in Company
17th Mar 20262:07 pmRNSDirector/PDMR Shareholding
12th Mar 202610:03 amRNSAnnual Financial Report
12th Mar 202610:03 amRNSAnnual Financial Report
5th Mar 20267:00 amRNS2025 Full Year Results
11th Feb 202611:00 amRNSChanges to Director's Responsibilities
9th Feb 20262:07 pmRNSHolding(s) in Company
6th Feb 20262:00 pmRNSDirector Declaration
17th Dec 20252:00 pmRNSDirector/PDMR Shareholding
7th Nov 20257:00 amRNSTrading Statement
5th Nov 20252:45 pmRNSDirector Declaration
30th Oct 20257:00 amRNSCompletion of OrthoLite acquisition
20th Oct 202512:41 pmRNSDirector/PDMR Shareholding
17th Oct 20251:42 pmRNSHolding(s) in Company
6th Oct 20251:06 pmRNSBlock listing Interim Review
16th Sep 20252:00 pmRNSDirector Declaration
12th Sep 20253:22 pmRNSHolding(s) in Company
11th Sep 20253:13 pmRNSHolding(s) in Company
10th Sep 20251:09 pmRNSDirector/PDMR Shareholding
3rd Sep 202512:58 pmRNSHolding(s) in Company
11th Aug 202511:03 amRNSHolding(s) in Company
5th Aug 202510:44 amRNSHolding(s) in Company
31st Jul 202512:39 pmRNSTotal Voting Rights
29th Jul 20257:00 amRNSFurther Information re Acquisition of OrthoLite
23rd Jul 20259:26 amRNSHolding(s) in Company
22nd Jul 202510:31 amRNSHolding(s) in Company
21st Jul 20253:25 pmRNSDirector/PDMR Shareholding
21st Jul 20252:30 pmRNSHolding(s) in Company
21st Jul 20252:27 pmRNSHolding(s) in Company
17th Jul 20256:00 pmRNSCoats Group
17th Jul 20257:00 amRNSResults of Capital Raise
16th Jul 20255:47 pmRNSAcquisition - Retail Offer Launch (Replacement)
16th Jul 20254:50 pmRNSAcquisition - Retail Offer Launch
16th Jul 20254:46 pmRNSAcquisition - Capital Raise Launch
16th Jul 20254:45 pmRNSHalf-year Report
16th Jul 20254:45 pmRNSAcquisition
27th Jun 20251:06 pmRNSHolding(s) in Company
24th Jun 20257:00 amRNSDirectorate Change
4th Jun 20251:42 pmRNSDirector/PDMR Shareholding
23rd May 202511:32 amRNSDirector/PDMR Shareholding
21st May 20253:58 pmRNSResult of AGM
21st May 20257:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.